|
Volumn 118, Issue 1, 2002, Pages 117-123
|
Variable product purity and functional capacity after CD34 selection: A direct comparison of the CliniMACS® (v2.1) and Isolex® 300i (v2.5) clinical scale devices
|
Author keywords
(v2.1); 300i (v2.5); Apoptosis; CD34+ product functional capacity; CD34+ selection; CliniMACS ; Isolex
|
Indexed keywords
CD34 ANTIGEN;
LIPOCORTIN 5;
ANTIGEN PURIFICATION;
APHERESIS;
APOPTOSIS;
ARTICLE;
CELL CULTURE;
CELL LINEAGE;
CELL SPECIFICITY;
CLINICAL ARTICLE;
COLONY FORMING UNIT;
CONTROLLED STUDY;
DEVICE;
ERYTHROID CELL;
GRANULOCYTE;
HUMAN;
HUMAN CELL;
INTERMETHOD COMPARISON;
PRIORITY JOURNAL;
PROTEIN BINDING;
STEM CELL;
T LYMPHOCYTE;
ANTIGENS, CD34;
B-LYMPHOCYTES;
BLOOD COMPONENT REMOVAL;
CELL MOVEMENT;
CLONE CELLS;
HUMANS;
LYMPHOCYTE COUNT;
LYMPHOCYTES;
STEM CELLS;
|
EID: 0036062908
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2002.03561.x Document Type: Article |
Times cited : (35)
|
References (23)
|